Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Repeated antidepressant therapy increases cyclic GMP signaling in rat hippocampus

Simple item page
dc.contributor.authorReierson, Gillian W.
dc.contributor.authorMastronardi, Claudio
dc.contributor.authorLicinio, Julio
dc.contributor.authorWong, Ma-Li
dc.date.accessioned2015-12-08T22:36:28Z
dc.date.issued2009
dc.date.updated2016-02-24T11:37:43Z
dc.description.abstractCyclic adenosine monophosphpate (cAMP) signaling is thought to be involved in the pathophysiology of major depressive disorder and antidepressant action; however, relatively little is known about the possible role of cyclic guanosine monophosphate (cGMP)
dc.identifier.issn0304-3940
dc.identifier.urihttp://hdl.handle.net/1885/35270
dc.publisherElsevier
dc.sourceNeuroscience Letters
dc.subjectKeywords: amitriptyline; antidepressant agent; cyclic GMP; fluoxetine; phosphodiesterase; animal experiment; animal tissue; article; controlled study; drug effect; drug efficacy; drug mechanism; gene expression; hippocampus; male; nonhuman; nucleotide sequence; pri Antidepressant; Cyclic; Hippocampus; Nucleotides; Phosphodiesterase; Rat
dc.titleRepeated antidepressant therapy increases cyclic GMP signaling in rat hippocampus
dc.typeJournal article
local.bibliographicCitation.lastpage153
local.bibliographicCitation.startpage149
local.contributor.affiliationReierson, Gillian W., University of Miami
local.contributor.affiliationMastronardi, Claudio, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationLicinio, Julio, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationWong, Ma-Li, College of Medicine, Biology and Environment, ANU
local.contributor.authoruidMastronardi, Claudio, u4776074
local.contributor.authoruidLicinio, Julio, u4761348
local.contributor.authoruidWong, Ma-Li, u4779029
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor110319 - Psychiatry (incl. Psychotherapy)
local.identifier.absfor111505 - Pharmacogenomics
local.identifier.absfor110903 - Central Nervous System
local.identifier.ariespublicationu6800332xPUB122
local.identifier.citationvolume466
local.identifier.doi10.1016/j.neulet.2009.09.047
local.identifier.scopusID2-s2.0-70350347177
local.identifier.thomsonID000271852700010
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
01_Reierson_Repeated_antidepressant_2009.pdf
Size:
375.47 KB
Format:
Adobe Portable Document Format
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS